结论：DZ选择性地抑制了AP在人体肝脏中的4羟基化代谢途径，提示DZ是一作用较强的、选择性的肝药酶抑制剂。
CONCLUSION:DZ inhibited the 4 hydroxytative metabolic pathway of AP, suggesting DZ may be a potent and selective microsomal enzyme inhibitor.
通过本文的研究为以后开发糖苷酶抑制剂药及生物农药提供了一定的理论基础。
All of studies in this dissertation offer references to research and development of glycosidase inhibitor medicine and bio-pesticide.
还对分化诱导剂、拓扑异构酶抑制剂、抗微管药和生物反应调节剂的筛选方法进行了评述。
In addition, the paper reviewed screening methods for differentiation inducers, DNA topoisomerase inhibitors, antimicrotubule drugs and biological response modifiers.
血管紧张素转化酶抑制剂和血管紧张素受体拮抗剂联合用药治疗CKD是否比单药应用要好？
Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination therapy Better Than Monotherapy and Safe in Patients With CKD?
蛋白酶体抑制剂可选择性地促进肿瘤细胞凋亡，逆转多药耐药。
Proteasome inhibitors can selectively promote the apoptosis of tumor cells and overcome MDR.
目的介绍选择性环氧化酶（COX）-2抑制剂与抗炎植物药研究概况。
Objective To review the research progress of selective cyclooxygenase-2 (COX-2) inhibitors and anti-inflammatory herbs.
我们比较了血管紧张素转换酶抑制剂雷米普利、血管紧张素受体拮抗剂替米沙坦以及两药联合对有血管性疾病或高位糖尿病患者的作用。
We compared the ACE inhibitor ramipril, the ARB telmisartan, and the combination of the two drugs in patients with vascular disease or high-risk diabetes.
其研究结果将为合理设计新型顶体酶抑制剂，寻找男性口服避孕药奠定坚实基础。
These results provided a basis for the rational design of specific inhibitors to the target enzyme and the discovery of novel contraceptive agents with high potency.
该药与芳香化酶抑制剂联合使用治疗HER2和激素受体共同阳性乳腺癌的绝经后女性。
It is also approved for use in combination with an aromatase inhibitor for the treatment of postmenopausal patients with HER2 and hormone receptor co-positive metastatic breast cancer.
抗肿瘤药罗米地辛是一种有效的组蛋白去乙酰化酶抑制剂，临床 上用于治疗皮肤T细胞淋巴瘤。
Romidepsin is a potent histone deacetylase inhibitor, and is used in the treatment of cutaneous T-cell lymphoma (CTCL).
目的介绍抗高血压药血管紧张素转化酶抑制剂（ACEI）依那普利的研发及市场情况。
Objective To introduce the research and market development of enalapril as an angiotensin 1-converting enzyme inhibitor (ACEI) for treating hypertension.
酶抑制引言几乎所有的治疗药物是酶抑制剂，从老药，如阿司匹林与青霉素用于治疗艾滋病毒感染的最新化合物框标准。
Enzyme Inhibition INTRODUCTION Almost all therapeutic drugs are enzyme inhibitors, from old medicine box standards such as aspirin and penicillin to the newest compounds used to treat HIV infection.
本发明还提供了胆碱酯酶抑制剂在制备用于治疗口腔干燥症的对口腔粘膜局部给药的药物方面的用途。
The invention also provides a use of cholinesterase inhibitor in the treatment of xerostomia for topical delivery to the oral mucosa.
环氧化酶-2抑制剂和大多数的非甾体类消炎药（NSAIDs）的抗心血管疾病的效果并没有肯定，还需进一步研究。
The effect of cyclooxygenase-2 inhibitors and most nonsteroidal anti-inflammatory drugs (NSAIDs) on cardiovascular risk is not completely determined and should be studied further.
结果钙拮抗剂、肾上腺素受体阻滞药、血管紧张素转化酶抑制剂(acei)在用药金额、用药频度上分别占前三位。
Results the amount used DDDs of calcium antagonists, adrenergic receptor blockers and ACEI drugs were the head of three.
结果钙拮抗剂、肾上腺素受体阻滞药、血管紧张素转化酶抑制剂(acei)在用药金额、用药频度上分别占前三位。
Results the amount used DDDs of calcium antagonists, adrenergic receptor blockers and ACEI drugs were the head of three.
应用推荐